F
Frank R. DeLeo
Researcher at National Institutes of Health
Publications - 210
Citations - 28910
Frank R. DeLeo is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Staphylococcus aureus & Innate immune system. The author has an hindex of 86, co-authored 206 publications receiving 26462 citations. Previous affiliations of Frank R. DeLeo include Montana State University & University of Iowa.
Papers
More filters
Journal ArticleDOI
Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification
Adam D. Kennedy,Michael Otto,Kevin R. Braughton,Adeline R. Whitney,Liang Chen,Barun Mathema,José R. Mediavilla,Kelly A. Byrne,Larye D. Parkins,Fred C. Tenover,Barry N. Kreiswirth,James M. Musser,Frank R. DeLeo +12 more
TL;DR: It is demonstrated that there has been recent clonal expansion and diversification of a subset of isolates classified as USA300, adding an evolutionary dimension to the epidemiology and emergence of USA300 and suggesting a similar mechanism for the pandemic occurrence and spread of penicillin-resistant S. aureus in the 1950s.
Journal ArticleDOI
Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding
Liang Chen,Barun Mathema,Kalyan D. Chavda,Frank R. DeLeo,Robert A. Bonomo,Barry N. Kreiswirth +5 more
TL;DR: Recent progresses in understanding KPC-producing K. pneumoniae that are contributing to the authors' knowledge of plasmid and genome composition and structure among the KPC epidemic clone are discussed, and possible factors that influence its epidemiological success are identified.
Journal ArticleDOI
Neutrophil apoptosis and the resolution of infection
Adam D. Kennedy,Frank R. DeLeo +1 more
TL;DR: PMN apoptosis is reviewed and the ability of microorganisms to alter this important process is reviewed to cause disease.
Journal Article
Vancomycin Resistance in Staphylococcus aureus .
TL;DR: Progress made toward understanding the acquisition of antibiotic resistance in S. aureus is reviewed, with an emphasis on the molecular mechanisms underlying vancomycin resistance.
Journal ArticleDOI
Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils
Scott D. Kobayashi,Kevin R. Braughton,Adeline R. Whitney,Jovanka M. Voyich,Tom G. Schwan,James M. Musser,Frank R. DeLeo +6 more
TL;DR: It is hypothesize that there are two fundamental outcomes for the interaction of bacterial pathogens with neutrophils: (i) phagocytosis of bacteria induces an apoptosis differentiation program in human PMNs that contributes to resolution of bacterial infection, or (ii)PhagocyTosis of microorganisms such as Str. pyogenes alters the apoptosis differentiate program in neutrophil, resulting in pathogen survival and disease.